bromouracil has been researched along with Kaposi Disease in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, M | 1 |
| Iwai, S | 1 |
| Kuraoka, I | 1 |
1 other study available for bromouracil and Kaposi Disease
| Article | Year |
|---|---|
A non-isotopic assay uses bromouridine and RNA synthesis to detect DNA damage responses.
Topics: Biological Assay; Bromouracil; Cell Line; Cockayne Syndrome; DNA Damage; DNA Repair; HeLa Cells; Hum | 2010 |